There may be several mechanisms for reduced activation of the insulin signalling pathway in AD neurones, including the binding of Aβ to the insulin receptor and changes in the phosphorylation state of insulin receptor substrate 1 [37, 57, 70]. The gene discussed is INSR; the disease is Alzheimer disease.